Innovent Biologics and Eli Lilly and Company have jointly announced that the National Medical Products Administration (N...
Biocon has received the Certificate of GMP compliance from EMA for its Biologics Drug Product (DP) as well as Drug Subst...
Scientists from Nanyang Technological University, Singapore (NTU Singapore) have pinpointed how a special class of plant...
Alphamab Oncology, a leading biopharmaceutical company based in China dedicated to global development of innovative biol...
Researchers at Duke-NUS Medical School, Singapore have discovered “Sema3d”, a signalling protein that appear...
Prestige BioPharma has announced that European Medicines Agency (EMA) has validated and accepted for review the Mar...
A team of researchers at Singapore that deactivating a specific protein − interleukin 11 (IL11) – with drugs...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions fo...
Takeda Pharmaceutical Company has announced that the U.S. Food & Drug Administration (FDA) has accepted for rev...
Evolve BioSystems, makers of Evivo® baby probiotic, announced that its flagship consumer product Evivo is ...
Researchers in South Korea and Singapore have, for the first time, have developed a chemical probe that enables live-ima...
An international team led by Duke-NUS Medical School has found a potential link between autistic-like behaviour in adult...
Researchers at Okayama University in Japan have reported in the journal Sensors and Actuators B: Chemical that terahertz...
Scientists from Singapore's Agency for Science, Technology and Research (A*STAR), in collaboration with the Environmenta...
Scientists from the Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS), to...
Cognitive impairment associated with cancer, also known as “chemobrain”, has gained recognition as a complic...
An international research team led by Nanyang Technological University, Singapore (NTU Singapore) has found that patient...
New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for r...
